#$%^&*AU2018201985B220190718.pdf#####CYCLODEXTRIN AND ANTIBODY-DRUG CONJUGATE FORMULATIONS ABSTRACT Disclosed are formulations, including both liquid and lyophilized formulations, comprising a benzodiazepine antibody-drug conjugate (ADC) and a cyclodextrin. Also disclosed are methods of purifying mixtures comprising benzodiazepine antibody-drug conjugates and process drugrelated impurities.